SY-4798
/ Shouyao Holdings
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 11, 2023
A First-in-Human, Phase 1 Study of SY-4798 in Patients With Advanced Solid Tumor
(clinicaltrials.gov)
- P1 | N=80 | Recruiting | Sponsor: Shouyao Holdings (Beijing) Co. LTD | Trial completion date: Apr 2023 ➔ Apr 2024 | Trial primary completion date: Apr 2023 ➔ Apr 2024
Metastases • Trial completion date • Trial primary completion date • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor • FGF19
August 12, 2022
A First-in-Human, Phase 1 Study of SY-4798 in Patients With Advanced Solid Tumor
(clinicaltrials.gov)
- P1 | N=80 | Recruiting | Sponsor: Shouyao Holdings (Beijing) Co. LTD
New P1 trial • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor • FGF19
1 to 2
Of
2
Go to page
1